Advertisement
Screener

NASDAQ:SKIN | Increase (Decrease) in Accrued Liabilities | SkinHealth Systems Inc.

0.6 / 5 stars · 15/120 Roast Me

SkinHealth Systems Inc. Increase (Decrease) in Accrued Liabilities

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-03-01

  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $728.00K, a 92.05% decline year-over-year.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$4.47M, a 167.96% decline year-over-year.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $8.64M, a 114.37% increase year-over-year.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was -$8.25M, a 264.45% decline year-over-year.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$3.36M, a 113.55% decline from fiscal 2021.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $24.78M.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for fiscal 2020 was -$118.00K, a 104.27% decline from fiscal 2019.
  • SkinHealth Systems Inc. increase (decrease) in accrued liabilities for fiscal 2019 was $2.77M.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2022-12-31$728.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$3.74M
derived: sum of 2 quarters · filed 2023-03-01
$4.89M
derived: sum of 3 quarters · filed 2023-03-01
-$3.36M
10-K · filed 2023-03-01
2022-09-30-$4.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$4.17M
derived: sum of 2 quarters · filed 2022-11-09
-$4.08M
10-Q · filed 2022-11-09
$5.08M
derived: sum of 4 quarters · filed 2023-03-01
2022-06-30$8.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$385.00K
10-Q · filed 2022-08-09
$9.54M
derived: sum of 3 quarters · filed 2023-03-01
$16.12M
derived: sum of 4 quarters · filed 2023-03-01
2022-03-31-$8.25M
10-Q · filed 2022-05-10
$908.00K
derived: sum of 2 quarters · filed 2023-03-01
$7.49M
derived: sum of 3 quarters · filed 2023-03-01
$11.51M
derived: sum of 4 quarters · filed 2023-03-01
2021-12-31$9.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$15.74M
derived: sum of 2 quarters · filed 2023-03-01
$19.77M
derived: sum of 3 quarters · filed 2023-03-01
$24.78M
10-K · filed 2023-03-01
2021-09-30$6.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$10.61M
derived: sum of 2 quarters · filed 2022-11-09
$15.62M
10-Q · filed 2022-11-09
$16.38M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$4.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$9.05M
10-Q · filed 2022-08-09
$9.80M
derived: sum of 3 quarters · filed 2022-08-09
$9.80M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$5.02M
10-Q · filed 2022-05-10
$47.97K
10-Q · filed 2021-07-01
$5.77M
derived: sum of 2 quarters · filed 2022-05-10
$5.77M
derived: sum of 3 quarters · filed 2022-05-10
2020-12-31$752.55K
derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-28
$753.55K
10-K/A · filed 2021-05-28
-$118.00K
10-K · filed 2023-03-01
2020-09-30$1.00K
10-Q · filed 2020-11-16
-$1.82M
10-Q · filed 2021-11-12
2020-06-30-$6.77M
10-Q · filed 2021-08-13
2019-12-31$2.77M
10-K · filed 2022-03-01